InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: zoomboom post# 87883

Monday, 01/06/2014 7:34:53 PM

Monday, January 06, 2014 7:34:53 PM

Post# of 130516
the already have the Phase II candidate ..

Amarantus Seeks Candidate For PD-LID

On May 22, 2013, Amarantus entered into a letter of intent to in-license a phase 2 drug candidate in L-Dopa-Induced Dyskinesia (LID) in patients with Parkinson's Disease from an undisclosed third party. Once the license is complete, Amarantus plans to initiate a phase 2b trial within 12 months.